메뉴 건너뛰기
Pediatric Nephrology
Volumn 25, Issue 12, 2010, Pages 2547-2548
CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency
Author keywords

[No Author keywords available]
Indexed keywords

BASILIXIMAB; COBALAMIN; CYCLOSPORIN A; HOMOCYSTEINE; MEMBRANE COFACTOR PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SILDENAFIL;
EID: 78449267023     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1609-8     Document Type: Letter
Times cited : (28)
References (4)
  • 1
    • 68449088805 scopus 로고    scopus 로고
    • Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome
    • 10.1007/s00467-009-1188-8 19373492
    • JC Davin N Buter JW Groothoff J van Wijk AH Bouts L Strain T Goodship 2009 Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome Pediatr Nephrol 24 1757 1760 10.1007/s00467-009-1188-8 19373492
    • (2009) Pediatr Nephrol , vol.24 , pp. 1757-1760
    • Davin, J.C.1    Buter, N.2    Groothoff, J.W.3    Van Wijk, J.4    Bouts, A.H.5    Strain, L.6    Goodship, T.7
  • 2
    • 33751035523 scopus 로고    scopus 로고
    • Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome
    • 1:CAS:528:DC%2BD28XhtFartLnI 10.1016/j.molimm.2006.07.004 16882452
    • A Richards MK Liszewski D Kavanagh CJ Fang E Moulton V Fremeaux-Bacchi G Remuzzi M Noris THJ Goodship JP Atkinson 2007 Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome Mol Immunol 44 111 122 1:CAS:528:DC%2BD28XhtFartLnI 10.1016/j.molimm.2006.07.004 16882452
    • (2007) Mol Immunol , vol.44 , pp. 111-122
    • Richards, A.1    Liszewski, M.K.2    Kavanagh, D.3    Fang, C.J.4    Moulton, E.5    Fremeaux-Bacchi, V.6    Remuzzi, G.7    Noris, M.8    Goodship, T.H.J.9    Atkinson, J.P.10
  • 3
    • 36048948905 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder
    • 10.1007/s00467-007-0604-1 17874135
    • AP Sharma CR Greenberg AN Prasad C Prasad 2007 Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder Pediatr Nephrol 22 2097 2103 10.1007/s00467-007-0604-1 17874135
    • (2007) Pediatr Nephrol , vol.22 , pp. 2097-2103
    • Sharma, A.P.1    Greenberg, C.R.2    Prasad, A.N.3    Prasad, C.4
  • 4
    • 0027531427 scopus 로고
    • Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
    • 1:CAS:528:DyaK3sXhsVCrsbw%3D 10.1172/JCI116187 8380812
    • JS Stamler JA Osborne O Jaraki LE Rabbani SD MullinsM J Loscalzo 1993 Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J Clin Invest 91 308 318 1:CAS:528:DyaK3sXhsVCrsbw%3D 10.1172/JCI116187 8380812
    • (1993) J Clin Invest , vol.91 , pp. 308-318
    • Stamler, J.S.1    Osborne, J.A.2    Jaraki, O.3    Rabbani, L.E.4    Mullinsm, S.D.5    Loscalzo, J.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.